Selective defects of T lymphocyte function in patients with lethal intraabdominal infection

American Journal of Surgery

Volumn 178, Issue 4, 1999, Pages 288-292

  Heidecke, Claus Dieter ^a   Hensler, Thorsten ^a   Weighardt, Heike ^a   Zantl, Niko ^a   Wagner, Hermann ^a   Siewert, Jörg Rüdiger ^a   Holzmann, Bernhard ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL INFECTION; ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; IMMUNITY; LYMPHOCYTE FUNCTION; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SEPSIS; T LYMPHOCYTE;

ABDOMEN; AGED; CELL DIVISION; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKINS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032701390     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)00183-X     Document Type: Article

References (31)

1. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:1998;275-283.
2. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
3. Allen J.E., Maizels R.M. Th1-Th2 reliable paradigm or dangerous dogma? Immunol Today. 18:1997;387-392.
4. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immuno. 12:1994;227-257.
5. Kelso A. Th1 and Th2 subsets paradigms lost? Immunol Today. 16:1995;374-379.
6. Wood J.J., Rodrick M.L., O'Mahony J.B., et al. Inadequate interleukin-2 production a fundamental immunological deficiency in patients with major burns . Ann Surg. 200:1984;311-320.
7. Faist E., Mewes A., Baker C.C., et al. Prostaglandin E2 (PGE2)-dependent suppression of interleukin-2 (IL-2) production in patients with major trauma. J Trauma. 27:1987;837-848.
8. Faist E., Schinkel C., Zimmer S., et al. Inadequate interleukin-2 synthesis and interleukin-2 messenger expression following thermal and mechanical trauma in humans is caused by defective transmembrane signalling. J Trauma. 43:1993;846-853.
9. Abraham E., Regan R.F. The effects of hemorrhage and trauma on interleukin-2 production. Arch Surg. 120:1985;1341-1344.
10. O'Sullivan S.T., Lederer J.A., Horgan A.F., et al. Major injury leads to predominance of the T helper-2-lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg. 222:1995;482-492.
11. Naldini A., Borrelli E., Cesari S., et al. In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary by-pass. Cytokine. 7:1995;165-170.
12. Hensler T., Hecker H., Heeg K., et al. Distinct mechanisms of immunosuppression as a consequence of major surgery. Int Immunol. 65:1997;2283-2291.
13. Brune I.B., Wilke W., Hensler T., et al. Down-regulation of Th1 immune response and altered pro- and anti-inflammatory T cell cytokine balance following conventional, but not laparoscopic surgery. Am J Surg. 177:1999;55-60.
14. Decker D., Schöndorf M., Bidlingmaier F., et al. Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery. 119:1996;316-325.
15. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 101:1992;1644-1655.
16. Munoz C., Carlet J., Fitting C., et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest. 88:1991;1747-1754.
17. Faist E., Storck M., Hültner L., et al. Functional analysis of monocyte activity through synthesis patterns of proinflammatory cytokines and neopterin in patients in surgical intensive care. Surgery. 112:1992;562-572.
18. Ertel W., Kremer J.P., Kennedy J., et al. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood. 85:1995;1341-1347.
19. Bretscher P. The two-signal model of lymphocyte activation twenty-one years later. Immunol Today. 13:1992;74-76.
20. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu Rev Immunol. 14:1996;233-258.
21. Ayala A., Deol Z.K., Lehman D.L., et al. Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-γ release while increasing IL-4/IL-10 production. J Surg Res. 56:1994;579-585.
22. Horgan P.G., Mannick J.A., Dubravec D.B., Rodrick M.L. Effect of low dose recombinant interleukin 2 plus indomethacin on mortality after sepsis in a murine model. Br J Surg. 77:1990;401-404.
23. Gough D.B., Moss N.M., Jordan A., et al. Recombinant interleukin-2 (rIL-2) improves immune response and host resistance to septic challenge in thermally injured mice. Surgery. 104:1988;292-300.
24. Walley K.R., Lukacs N.W., Standiford T.J., et al. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun. 64:1996;4733-4738.
25. Sheppard B.C., Fraker D.L., Norton J.A. Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor. Surgery. 106:1989;156-162.
26. Echtenacher B., Falk W., Männel D.N., Krammer P.H. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol. 145:1990;3762-3766.
27. Echtenacher B., Männel D.N., Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature. 381:1996;75-77.
28. Malaviya R., Ikeda T., Ross E., Abraham S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α Nature. 381:1996;77-80.
29. Fisher C.J., Agost J.M., Opal S.M., et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. NEJM. 334:1996;1697-1702.
30. Bone R.C. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 24:1996;1125-1128.
31. Bone R.C., Grodzin C.J., Balk R.A. Sepsis a new hypothesis for pathogenesis of the disease process . Chest. 112:1997;235-243.